The biopharma space has stepped up its efforts to both prevent and treat the coronavirus (SARS-CoV-2) that is threatening to bring the world to its knees.
This article challenges the efficacy of trypan blue dye exclusion for assessing cell viability and offers a new model for evaluating cell life and death.
Sponsored
Ramon LeDoux from the Bio/Pharma Systems Group of YMC Process Technnologies, Inc., spoke on at the CPhI Theater on scaling multicolumn chromatography processes using a twin-column approach.
